Serious but rarer risks include pancreatitis, gallbladder disease, and increased heart rate
Escitalopram, a selective serotonin reuptake inhibitor (SSRI) antidepressant, and Wegovy (semaglutide), a GLP-1 receptor agonist for weight management, work through entirely different mechanisms
The degree of weight loss achieved also matterspatients who reach a healthy weight range and maintain it for an extended period while on medication may attempt discontinuation differently than those who achieve modest weight reduction
Suppression of food intake by Glp1r/Lepr- coexpressing neurons prevents obesity in mouse models
However, the magnitude of impact for most of these agents to reverse iatrogenic weight gain tends to be modest, particularly once significant weight gain (ie, 7% of initial body weight) has already occurred
Industry analysts note that the compounded semaglutide price can be significantly impacted by location, as urban pharmacies often face higher overheads